Literature DB >> 3538663

Therapeutic drug monitoring.

W H Bayer.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3538663      PMCID: PMC1307007     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  9 in total

1.  Association between clinical cardiac status, laboratory parameters, and digoxin usage.

Authors:  D H Huffman; J W Crow; P Pentikäinen; D L Azarnoff
Journal:  Am Heart J       Date:  1976-01       Impact factor: 4.749

2.  Drug therapy. Serum drug concentrations as therapeutic guides.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

3.  Choosing optimal sampling times for therapeutic drug monitoring.

Authors:  G E Schumacher
Journal:  Clin Pharm       Date:  1985 Jan-Feb

4.  Serum digoxin concentration and diagnosis of digitalis toxicity. Current concepts.

Authors:  T H Lee; T W Smith
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

5.  The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

Authors:  R D Moore; C R Smith; P S Lietman
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

6.  Diagnostic decision. The measurement of anticonvulsant agent levels.

Authors:  A S Troupin
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

Review 7.  Theophylline reassessed.

Authors:  M Bukowskyj; K Nakatsu; P W Munt
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

8.  Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.

Authors:  P Noone; T M Parsons; J R Pattison; R C Slack; D Garfield-Davies; K Hughes
Journal:  Br Med J       Date:  1974-03-16

Review 9.  Reliability of antiarrhythmic drug plasma concentration monitoring.

Authors:  F Follath; U Ganzinger; E Schuetz
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.